United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

23 Aug 2019
Change (% chg)

HK$0.45 (+1.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Yao, Fang 

Mr. Yao Fang is a Chief Supervisor of Sinopharm Group Co., Ltd. has served as the Supervisor of the Company since 7 January 2011. Mr. Yao obtained a bachelor’s degree in economics from Fudan University in July 1989 and a master of business administration degree from The Chinese University of Hong Kong in December 1993. Between 1993 and 2009, Mr. Yao served as assistant general manager of the international business department of Shanghai Wanguo Securities Co., Ltd. (currently known as Shenwan Hongyuan Group Co., Ltd.), general manager of Shanghai Shang Shi Assets Operation and Management Co., Ltd. and Shang Shi Management (Shanghai) Co., Ltd., managing director of Shanghai Industrial Pharmaceutical Investment Co., Ltd. (delisted on 12 February 2010), the chairman of Shanghai Overseas Co., Ltd., non-executive director of Lianhua Supermarket Holdings Co., Ltd. (stock code 0980), and executive director of Shanghai Industrial Holding Limited (stock code: 0363) listed on the Hong Kong Stock Exchange. Mr. Yao has served as a non-executive director of Biosino Bio- Technology and Science Incorporation (stock code: 8247) listed on the Hong Kong Stock Exchange from 24 January 2011 to 13 March 2014. Mr. Yao joined Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since April 2010. He currently serves as the executive director and co-president of Shanghai Fosun Pharmaceutical (Group) Co., Ltd..

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li


Yong Liu


Qiyu Chen


Xiuchang Jiang


Maisong Cai


Jun Lu

As Of  31 Dec 2017